David Spetzler

Caris Life Sciences has appointed David Spetzler its chief scientific officer. He was previously the company's senior vice president of R&D, and in his new role Spetzler will assume all responsibilities for Caris' research and product development efforts. A key new priority will be expanding the firm's focus on its Carisome TOP platform, a blood-based profiling technology being evaluated for applications in drug development and drug delivery, as well as for its diagnostic, prognostic, and theranostic use in cancer and other complex diseases, Caris said.